Los Angeles Capital Management LLC lifted its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 25.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,150 shares of the scientific and technical instruments company's stock after purchasing an additional 8,159 shares during the period. Los Angeles Capital Management LLC owned 0.09% of Itron worth $4,288,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in ITRI. Jupiter Asset Management Ltd. purchased a new stake in shares of Itron during the first quarter valued at approximately $2,029,000. Sculptor Capital LP purchased a new position in shares of Itron in the 2nd quarter valued at about $5,255,000. UniSuper Management Pty Ltd purchased a new position in Itron during the first quarter worth approximately $904,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its position in shares of Itron by 113.0% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 30,988 shares of the scientific and technical instruments company's stock worth $2,867,000 after buying an additional 16,441 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Itron by 7.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 268,379 shares of the scientific and technical instruments company's stock valued at $26,559,000 after acquiring an additional 19,387 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
Insider Buying and Selling
In other news, CEO Thomas Deitrich sold 887 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $90,607.05. Following the sale, the chief executive officer now directly owns 205,276 shares of the company's stock, valued at approximately $20,968,943.40. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Thomas Deitrich sold 887 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $102.15, for a total transaction of $90,607.05. Following the sale, the chief executive officer now directly owns 205,276 shares of the company's stock, valued at approximately $20,968,943.40. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Joan S. Hooper sold 509 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $51,994.35. Following the sale, the chief financial officer now directly owns 72,338 shares of the company's stock, valued at $7,389,326.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,276 shares of company stock worth $4,517,947 in the last three months. 1.45% of the stock is owned by insiders.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. BNP Paribas initiated coverage on Itron in a research report on Thursday, September 5th. They set an "outperform" rating and a $133.00 target price on the stock. Oppenheimer boosted their target price on Itron from $120.00 to $124.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. JPMorgan Chase & Co. increased their price objective on Itron from $104.00 to $112.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 16th. Robert W. Baird upped their price target on shares of Itron from $123.00 to $132.00 and gave the company an "outperform" rating in a research report on Friday, November 1st. Finally, TD Cowen lifted their target price on shares of Itron from $125.00 to $136.00 and gave the stock a "buy" rating in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $123.92.
Get Our Latest Research Report on Itron
Itron Price Performance
ITRI stock traded down $1.96 during midday trading on Wednesday, hitting $119.27. The company's stock had a trading volume of 308,263 shares, compared to its average volume of 524,182. The company has a 50 day moving average of $107.11 and a two-hundred day moving average of $104.22. The firm has a market capitalization of $5.38 billion, a price-to-earnings ratio of 24.44, a price-to-earnings-growth ratio of 0.91 and a beta of 1.46. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. Itron, Inc. has a 12 month low of $64.55 and a 12 month high of $124.90.
Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.13 by $0.71. Itron had a net margin of 9.37% and a return on equity of 19.03%. The firm had revenue of $615.46 million for the quarter, compared to analyst estimates of $596.41 million. During the same quarter in the previous year, the company earned $0.98 EPS. The business's revenue for the quarter was up 9.8% compared to the same quarter last year. On average, analysts expect that Itron, Inc. will post 5.33 EPS for the current year.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Read More
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.